Our research involved a synergistic approach (Figure 9) [43,46,60], integrating wet bench experiments with in silico structural-based work to identify a novel host protein kinase and a specific inhibitor as a potential anti-COVID-19 target. Here, WEE1 is linked to COVID-19.